Page 55 - memoria2020online
P. 55
Memoria de actividades
2020
A Phase II Prospective, Randomized, S.S, Khojasteh M, Symmans W.F, Sotiriou C,
Double-Blind, Placebo-Controlled and Gonzalez-Ericsson P, Pogue-Geile K.L, Kim
Multicenter Clinical Trial to Assess R.S, Rimm D.L, Viale G, Hewitt S.M, Bartlett
the Safety of 0.005% Estriol Vaginal J.M.S, Penault-Llorca F, Goel S, Lien H, Loibl
Gel in Hormone Receptor-Positive S, Kos Z, Loi S, Hanna M.G, Michiels S, Kok
Postmenopausal Women with Early M, Nielsen T.O, Lazar A.J, Bago-Horvath Z,
Stage Breast Cancer in Treatment with Kooreman L.F.S, van der Laak J.A.W.M, Saltz
Aromatase Inhibitor in the Adjuvant J, Gallas B.D, Kurkure U, Barnes M, Salgado
Setting R, Cooper L.A.D, International Immuno-
Oncology Biomarker Working
Sánchez-Rovira P, Lindén Hirschberg A, Gil-Gil Group Collaborators.
M, Bermejo-De Las Heras B, Nieto-Magro C
NPJ Breast Cancer. 2020 May 12;6:16.
Oncologist. 2020 May 27. https://doi.org/10.1038/s41523-020-0154-2
https://doi.org/10.1634/theoncologist.2020-0417
IF: 4,983
IF: 5,025
GEICAM Guidelines for the Pitfalls in Assessing Stromal Tumor INVESTIGACIÓN Y PUBLICACIONES - Listado de artículos
Management of Patients with Infiltrating Lymphocytes (sTILs) in
Breast Cancer During the COVID-19 Breast Cancer. A report from the
Pandemic in Spain International Immuno-Oncology
Biomarker Group
Martin M, Guerrero-Zotano A, Montero
A, Jara C, Filipovich E, Rojo F, Moreno F, Kos Z, Roblin E , Kim R.S, Michiels S, Gallas
García Sáenz J.A, Alés J.E, Chacón J.I, Cruz B.D, Chen W, van de Vijver K.K et al (…)
J, Gimenez J, Cruz-Merino L, Algara M, on behalf of the International Immuno-
Santisteban M, López Tarruella S. On behalf Oncology Biomarker Working Group
of the GEICAM Spanish Breast Cancer
Group Steering Committee NPJ Breast Cancer. 2020 May 12;6:17.
https://doi.org/10.1038/s41523-020-0156-0
Oncologist. 2020 Sep;25(9):e1339-e1345.
https://doi.org/10.1634/theoncologist.2020-0363 IF: 4,983
IF: 5,025 Primary breast cancer and health
related quality of life in Spanish
Report on Computational Assessment women: The EpiGEICAM case-control
of Tumor Infiltrating Lymphocytes study
From the International Immuno-
Oncology Biomarker Working Group Fernandez de Larrea N, Perez-Gomez B,
Guerrero-Zotano A, Casas AM, Bermejo
Amgad M, Stovgaard E.S, Balslev E, Thagaard B, Baena-Cañada JM, Antolin S, Sanchez
J, Chen W, Dudgeon S, Sharma A, Kerner J.K, Rovira P, Ramos Vazquez M, Garcia-Saenz
Denkert C, Yuan Y, AbdulJabbar K, Wienert S, JA, Anton Torres A, Muñoz M, de Juan
Savas P, Voorwerk L, Beck A.H, Madabhushi A, Jara C, Chacón I, Arcusa A, Gil-Gil M,
A, Hartman J, Sebastian M.M, Horlings Adrover E, Oltra A, Brunet J, González S,
H.H, Hude ek J, Ciompi F, Moore D.A, Singh Bezares S, Lope V, Martin M, Pollan M
R, Roblin E, Balancin M.L, Mathieu M.C,
Lennerz J.K, Kirtani P, Chen I.C, Braybrooke Sci Rep. 2020 May 8;10(1):7741.
J.P, Pruneri G, Demaria S, Adams S, Schnitt
S.J, Lakhani S.R, Rojo F, Comerma L, Badve https://doi.org/10.1038/s41598-020-63637-w
IF: 3,998
55
